Most Recent
Merck KGaA has failed to block Pfizer’s 'Abrysvo' trade mark for its RSV vaccine, with a delegate finding no likelihood of confusion with the mark for Merck’s Mavenclad MS drug despite their visual similarities.
Gaming company Light & Wonder will pay $190 million to settle Aristocrat’s litigation in Australia and the United States alleging it misappropriated trade secrets in developing two poker machines.
Otsuka Pharmaceuticals has asked the High Court to overturn a decision revoking its Abilify patent extension, saying the ruling, which limited the extension-of term scheme to active substances only, will “lead to a groundswell of court proceedings”.
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.
The CSIRO has successfully appealed a decision that blocked the government agency’s application to patent a method of producing high-fibre wheat.
The High Court has unanimously granted home retailer Bed Bath N’ Table’s appeal of a ruling that retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
After years of pre-trial stoushes, a trademark dispute over Russian vodka has worn a Federal Court judge's patience thin, with the judge remarking that the court was entitled to expect better from the litigants.
Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno's generic version of schizophrenia drug Invega Sustenna.
A wellness retreat has launched an intellectual property suit against luxury Queensland resort Elysium Noosa, claiming that a recent rebrand amounts to passing off.
The High Court will not hear sports merchandise company Fanatics' trade mark fight with AFL apparel maker FanFirm, which Fanatics argued would provide guidance on the defence of honest concurrent use.